OpenEvidence (Series A)

Funding Details
Awarder
Inbox
Date Award
February 19, 2025
Vertical
Healthcare
Funding URL
View Funding Page
Valuation
$1,000,000,000

Company Info
Founding Year
2021
Traction
The product has grown organically thanks to word of mouth between doctors, with a quarter of U.S. doctors already using it.
Organizations Involved
The New England Journal of Medicine
Founders
Daniel Nadler
Company Description
OpenEvidence is an AI copilot for physicians that helps them make better decisions at the point of care. The company claims it’s already being used by a quarter of doctors in the U.S.
Market
AI for physicians
Location
Cambridge, Massachusetts, USA

Links
Back to Home Back to Healthcare Deals View Funding Announcement